Taking it all together, sPLA2-IIA showed superior overall performance compared to CD64 in diagnosing sepsis and bacterial infection, and could be used as a good biomarker for this purpose, either singly or in combination with other biomarkers. Here, FCGR1A is linked to bacterial infectious disease.